TTMI stock soars to 52-week high, touches $25.49 amid growth

Published 12/11/2024, 10:32 PM

In a remarkable display of market confidence, TTM Technologies , Inc. (NASDAQ:TTMI) stock has reached a 52-week high, climbing to $25.49. This peak reflects a significant surge in value, with the company's stock price experiencing an impressive 68.54% increase over the past year. According to InvestingPro data, the stock's technical indicators suggest it's in overbought territory, with analysts setting price targets ranging from $25 to $30. Investors have shown increasing enthusiasm for TTMI, a leading global printed circuit board (PCB) manufacturer, as the company capitalizes on the growing demand for complex PCBs used in various applications, from 5G infrastructure to aerospace and defense. The 52-week high milestone underscores the company's strong performance and the positive outlook held by shareholders and market analysts alike. With a market capitalization of $2.57 billion and a current ratio of 2.0, TTMI maintains strong liquidity. For deeper insights into TTMI's valuation and growth prospects, including 12+ additional exclusive ProTips, check out the comprehensive analysis available on InvestingPro.

In other recent news, TTM Technologies has been making headlines with significant developments. The company reported robust financial results for the third quarter of 2024, highlighting a revenue increase to $616.5 million, up from $572.6 million in the same period last year. TTM also posted a substantial improvement in net income, reporting $14.3 million, a notable turnaround from a net loss of $37.1 million in Q3 2023.

Needham, a well-known analyst firm, has maintained a Buy rating on TTM Technologies, raising its price target from $26.00 to $30.00. This optimistic outlook is based on strong fundamentals that are supporting the company's growth. The firm anticipates continued growth in TTM's largest market vertical, Aerospace & Defense, and the Data Center Computing business, which are contributing significantly to the company's revenues.

Furthermore, TTM's Medical (TASE:PMCN), Industrial & Instrumentation business is expected to recover gradually in 2025, aligning with an improving macroeconomic environment. Despite the Automotive sector likely facing a downturn, the firm remains confident in TTM's growth prospects. These recent developments indicate a positive outlook for TTM Technologies, underpinned by strong financial performance and a favorable rating from analysts.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.